Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2000
03/28/2000US6043077 Directed aganist specific nucleotide sequences to inhibit replication, infectivity, or gene expression of the virus; for prevention or viricides with side effect reduction
03/28/2000US6043071 GlmU
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6043053 Wnt-3 polynucleotides
03/28/2000US6042846 Resistant to nuclease hydrolysis; efficiency
03/28/2000US6042832 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
03/23/2000WO2000015853A1 Recombinant newcastle disease virus rna expression systems and vaccines
03/23/2000WO2000015845A1 T-type calcium channel
03/23/2000WO2000015843A1 Genetic suppression therapy
03/23/2000WO2000015826A2 Leptin induced genes
03/23/2000WO2000015825A1 Condensed plasmid-liposome complex for transfection
03/23/2000WO2000015824A1 Transfer method for specific cellular localisation of nucleic acids
03/23/2000WO2000015823A1 Alternatively targeted adenovirus
03/23/2000WO2000015822A1 Methods for treatment of degenerative retinal diseases
03/23/2000WO2000015821A1 Recombinant adenovirus for tissue specific expression in heart
03/23/2000WO2000015820A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
03/23/2000WO2000015819A1 Packaging cell lines for hiv-derived retroviral vector particles
03/23/2000WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical
03/23/2000WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
03/23/2000WO2000015800A2 Rac-like genes and methods of use
03/23/2000WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9)
03/23/2000WO2000015795A2 Genes from human chromosome 11p15.5
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015790A2 Leptin induced genes
03/23/2000WO2000015788A2 Dna sequence encoding oncofetal ferritin protein
03/23/2000WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015780A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer
03/23/2000WO2000015769A1 Topa
03/23/2000WO2000015666A2 Compositions and methods for the treatment of tumors
03/23/2000WO2000015649A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
03/23/2000WO2000015648A1 Adenoviral vector encoding pro-apoptotic bax gene and uses thereof
03/23/2000WO2000015641A1 Compounds alkylating specific base sequence of dna and method for synthesizing the same
03/23/2000WO2000015264A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
03/23/2000WO2000015263A1 Expandible microparticle intracellular delivery system
03/23/2000WO2000015260A1 Anti-ige gene therapy
03/23/2000WO2000015259A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells
03/23/2000WO2000015249A1 Treatment of kaposi's sarcoma with il-12
03/23/2000WO2000015246A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000WO2000015175A2 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells
03/23/2000WO2000004153A3 Repression of cell transformation with human pea3
03/23/2000WO2000002520A3 T-lymphocyte exchange
03/23/2000WO1999055876A3 Polypeptide with immunogenic properties and with a protein with modified biological functions
03/23/2000WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
03/23/2000CA2706859A1 Mammalian transforming growth factor beta - 9
03/23/2000CA2346262A1 Methods for treatment of degenerative retinal diseases
03/23/2000CA2344441A1 Expandible microparticle intracellular delivery system
03/23/2000CA2343654A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000CA2343355A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
03/23/2000CA2343354A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer
03/23/2000CA2343314A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
03/23/2000CA2342965A1 Leptin induced genes
03/23/2000CA2342601A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells
03/23/2000CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000CA2342396A1 Alternatively targeted adenovirus
03/23/2000CA2342301A1 Human cell junction pdz protein
03/23/2000CA2342292A1 Condensed plasmid-liposome complex for transfection
03/23/2000CA2341683A1 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000CA2340586A1 T-type calcium channel
03/22/2000EP0987327A1 Novel method for purifying covalently closed circular DNA
03/22/2000EP0987029A1 Use of a catonic polymer for the preparation of a complex with nucleic acid and related compositions
03/22/2000EP0986572A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
03/22/2000EP0986568A1 Novel class of nucleic acid cationic transfecting agents
03/22/2000EP0986404A2 Gene therapy delivery system for targeting to endothelia
03/22/2000EP0986401A1 P-selectin translocation to vascular epithelial lumen by ionizing radiation
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986372A1 Vesicular complexes and methods of making and using the same
03/22/2000CN1248290A Method for induction of apoptotic cell death in malignant cells, through reduction of the RB to apoptosis inducing proteins ratio
03/22/2000CN1050631C Preparation for high efficiency anti-tumor gama-type interferon mutant and use thereof
03/21/2000US6040296 Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
03/21/2000US6040295 Prolong the bioavailability of a nucleic acid molecule by injecting a solutions comprising a nucleic acid molecule and an amphiphilic compound select from polyvinyl pyrrolidone, polyvinyl alcohol, polyethylene glycol or propylene glycol
03/21/2000US6040181 Regulation of bcl-2 gene expression
03/21/2000US6040174 Defective adenoviruses and corresponding complementation lines
03/21/2000US6040172 Defective DNA viral vector comprising a neural tissue-specific promoter for in vivo expression of a gene
03/21/2000US6040164 Amino acid sequence of enzyme which binds to calmodulin in a calcium-dependent manner and is involved in calcium signalling; for screening agonists and antagonists
03/21/2000US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040157 Amino acid sequence; for angiogenesis inhibitors, antitumor agents, antiinflammatory agents, antiarthritic agents for rheumatoid arthritis, wound healing agents; treatment of diabetic retinopathy and psoriasis
03/21/2000US6040155 Isolated nucleic acid encoding a protease having chymotrypsin activity; viricides, fungicides, bactericides, parasiticides; treatment of herpes, leprosy, colitis, acne, hemorrhoids, corneal scarring, dental plaque, immune disorders, cancer
03/21/2000US6039941 Live vaccine for the treatment of tumor diseases
03/16/2000WO2000014262A2 Methylation of plasmid vectors
03/16/2000WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000WO2000014256A1 Gene therapy for treatment of cancer
03/16/2000WO2000014255A1 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES
03/16/2000WO2000014253A1 Nucleic acids and proteins from pineapple stem
03/16/2000WO2000014244A2 Treatment of cervical cancer
03/16/2000WO2000014240A2 Attenuated salmonella sp12 mutants as antigen carriers
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014234A1 Prostate specific promoter and regulation of gene expression
03/16/2000WO2000014233A1 14275 receptor, a novel g-protein coupled receptor related to the edg receptor family
03/16/2000WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000WO2000014228A1 Neutral amino acid transporter and gene thereof
03/16/2000WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
1 ... 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 ... 870